1
|
Mazzoli M, Ricci A, Vaudano AE, Marcacci M, Marchini S, Bergonzini P, Di Pierro E, Pischik E, Iughetti L, Pietrangelo A, Meletti S, Ventura P. Recovery of chronic motor neuropathy due to acute intermittent porphyria after givosiran treatment in a young boy: a case report. Eur Rev Med Pharmacol Sci 2024; 28:3268-3274. [PMID: 38708485 DOI: 10.26355/eurrev_202404_36055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/07/2024]
Abstract
BACKGROUND We describe the first case of a pediatric patient with acute intermittent porphyria and severe chronic porphyric neuropathy treated with givosiran, a small-interfering RNA that drastically decreases delta-aminolevulinic acid production and reduces porphyric attacks' recurrence. CASE REPORT A 12-year-old male patient with refractory acute intermittent porphyria and severe porphyric neuropathy was followed prospectively for 12 months after givosiran initiation (subcutaneous, 2.5 mg/kg monthly). Serial neurological, structural, and resting-state functional magnetic resonance imaging (MRI) evaluations were performed, including clinical scales and neurophysiological tests. Delta-aminolevulinic acid urinary levels dropped drastically during treatment. In parallel, all the administered neurological rating scales and neurophysiological assessments showed improvement in all domains. Moreover, an improvement in central motor conduction parameters and resting-state functional connectivity in the sensory-motor network was noticed. At the end of the follow-up, the patient could walk unaided after using a wheelchair for 5 years. CONCLUSIONS A clear beneficial effect of givosiran was demonstrated in our patient with both clinical and peripheral nerve neurophysiologic outcome measures. Moreover, we first reported a potential role of givosiran in recovering central motor network impairment in acute intermittent porphyria (AIP), which was previously unknown. This study provides Class IV evidence that givosiran improves chronic porphyric neuropathy.
Collapse
Affiliation(s)
- M Mazzoli
- Department of Biomedical, Metabolic and Neural Science, Neurology Unit, Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Bellini P, Ricci A, Setti G, Veneri F, Losi L, Chester J, Consolo U. Optimal time to definitive enucleation of large cysts following marsupialization: a single center, retrospective study. J Stomatol Oral Maxillofac Surg 2024:101837. [PMID: 38508396 DOI: 10.1016/j.jormas.2024.101837] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/21/2024] [Accepted: 03/16/2024] [Indexed: 03/22/2024]
Abstract
OBJECTIVES Optimal time to enucleation following marsupialization of large odontogenic mandibular cysts is undefined. We aim to assess volume reduction throughout follow-up, to indicate optimal time to enucleation. Secondary objectives include the identification of factors influencing cyst reduction. STUDY DESIGN We retrospectively enrolled 15 patients with mandibular cysts of different histological types treated with marsupialization at our center between 2018-2022. Cyst volume was assessed with cone-beam computed tomography (CBCT) and a semi-automatic segmentation algorithm, at baseline and between 6-8 months post marsupialization. RESULTS The overall mean cyst volume reduction percent (VR%) was 57.7% or 0.2% per day. VR% at 8 months was significantly higher than those assessed at 6-7 months (67.1% vs 47.1%, p=0.003). Time to CBCT was the only independent variable influencing cyst VR%. CONCLUSION Our study proves that the optimal time to enucleation for mandibular cyst is 8 months, independent of histological cyst type, patient age, baseline cyst volume and the number of pre-operative residual bone walls.
Collapse
Affiliation(s)
- Pierantonio Bellini
- Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology, and Regenerative Medicine Relevance, Unit of Dentistry and Oral-Maxillo-Facial Surgery, University of Modena and Reggio Emilia, Largo del Pozzo, 71, 41125, Modena, Italy
| | - Angelo Ricci
- Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology, and Regenerative Medicine Relevance, Unit of Dentistry and Oral-Maxillo-Facial Surgery, University of Modena and Reggio Emilia, Largo del Pozzo, 71, 41125, Modena, Italy
| | - Giacomo Setti
- Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology, and Regenerative Medicine Relevance, Unit of Dentistry and Oral-Maxillo-Facial Surgery, University of Modena and Reggio Emilia, Largo del Pozzo, 71, 41125, Modena, Italy.
| | - Federica Veneri
- Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Largo del Pozzo, 71, 41125, Modena, Italy
| | - Luca Losi
- Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology, and Regenerative Medicine Relevance, Unit of Dentistry and Oral-Maxillo-Facial Surgery, University of Modena and Reggio Emilia, Largo del Pozzo, 71, 41125, Modena, Italy
| | - Johanna Chester
- Department of Dermatology, University of Modena and Reggio Emilia, Largo del Pozzo, 71, 41125, Modena, Italy
| | - Ugo Consolo
- Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology, and Regenerative Medicine Relevance, Unit of Dentistry and Oral-Maxillo-Facial Surgery, University of Modena and Reggio Emilia, Largo del Pozzo, 71, 41125, Modena, Italy
| |
Collapse
|
3
|
Sposato B, Ricci A, Camiciottoli G, Carpagnano GE, Pelaia C, Santus P, Pelaia G, Palmiero G, Di Tomassi M, Ronchi MC, Cameli P, Bargagli E, Ciambellotti L, Rizzello S, Sglavo R, Coppola A, Lacerenza LG, Gabriele M, Radovanovic D, Perrella A, Rogliani P, Scalese M. Influence of allergic status and nasal polyposis on long-term Benralizumab response in eosinophilic severe asthma. Clin Ter 2023; 174:67-74. [PMID: 36655647 DOI: 10.7417/ct.2023.2499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Objective It is unclear whether Benralizumab effectiveness in severe eosinophilic asthma can be influenced by nasal polyposis (NP) or allergic status associations. We evaluated whether Benralizumab long-term efficacy in asthma outcomes could be different in subjects with atopy (SAEA) compared to the effectiveness in those without allergies (SNAEA) and in individuals with NP compared to those without NP. Methods This observational retrospective study considered 95 consecutive patients divided into allergic (SAEA; n:65[68.4%]; skin prick tests positive [SPT] and/or IgE values ≥100 UI/mL), and non-allergic (SNAEA; n:30[31.6%], SPT negative and normal IgE levels<100 UI/mL). Overall population was also divided into two groups according to NP presence (NP+:39[41%] and NP-:56[59%]). Benralizumab treatment mean was19.7±7.2 months (range 12-35). Results No differences in Benralizumab effectiveness were found in asthma outcomes in patients with/without NP. SNOT-22 improvement was higher in NP+ (-22±24) compared to NP- groups (6.33±15.5;p=0.055). FEV1 (16.33±19.22%), ACT(7.45±3.95) increases and frequency of SABA use (3.37±4.99) reduction were higher in SAEA compared to what obtained in non-allergic subjects (FEV1:8.15±15.6%,p=0.043; ACT:4.89±3.57,p=0.005; SABA use:-1.16±1.84;p=0.015). 93.8% of SAEA patients whereas only 72.2% of SNAEA individuals reduced OC doses at least half after Benralizumab (p=0.035). These results were partially confirmed by linear regression models showing associations between allergic status and FEV1, ACT and SABA use changes (β=8.37;p=0.048, β=2.056;p=0.033 and β=-2.184;p=0.042 respectively). Conclusion Benralizumab effectiveness in asthma appears to be independent of NP presence. The allergic eosinophilic disease, compared to just eosinophilic asthma, may be a more severe phenotype. Benralizumab may have greater efficacy in SAEA on some outcomes.
Collapse
Affiliation(s)
- B Sposato
- Pneumology Department, Azienda USL Toscana Sud-Est, "Misericordia" Hospital, Grosseto, Italy
| | - A Ricci
- Division of Pneumology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, AOU Sant'Andrea, Rome, Italy
| | - G Camiciottoli
- Section of Respiratory Medicine, Department of Experimental and Clinical Medicine, Careggi University Hospital, University of Florence, Florence, Italy
| | - G E Carpagnano
- Institute of Respiratory Diseases, Department of Medical and Surgical Sciences, University of Foggia, Italy
| | - C Pelaia
- Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University "Magna Græcia" of Catanzaro, Catanzaro, Italy
| | - P Santus
- Department of Biomedical and Clinical Sciences (DIBIC), Università Degli Studi di Milano, Division of Pulmonary Diseases, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco, Milan, Italy
| | - G Pelaia
- Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University "Magna Græcia" of Catanzaro, Catanzaro, Italy
| | - G Palmiero
- Pneumology Department, Azienda USL Toscana Nord Ovest, "Versilia" Hospital, Lido di Camaiore (LU), Italy
| | - M Di Tomassi
- Pneumology Department, Azienda USL Toscana Sud-Est, "S. Andrea" Hospital, Massa Marittima (GR), Italy
| | - M C Ronchi
- Pneumology Department, Azienda USL Toscana Sud-Est, "S. Andrea" Hospital, Massa Marittima (GR), Italy
| | - P Cameli
- Department of Medicine, Surgery and Neurosciences, Respiratory Diseases and Lung Transplant Unit, University of Siena, Siena, Italy
| | - E Bargagli
- Department of Medicine, Surgery and Neurosciences, Respiratory Diseases and Lung Transplant Unit, University of Siena, Siena, Italy
| | - L Ciambellotti
- Section of Respiratory Medicine, Department of Experimental and Clinical Medicine, Careggi University Hospital, University of Florence, Florence, Italy
| | - S Rizzello
- Section of Respiratory Medicine, Department of Experimental and Clinical Medicine, Careggi University Hospital, University of Florence, Florence, Italy
| | - R Sglavo
- Division of Pneumology, De-partment of Clinical and Molecular Medicine, Sapienza University of Rome, AOU Sant'Andrea, Rome, Italy
| | - A Coppola
- Division of Respiratory Disease, San Filippo Neri Hospital, Rome, Italy
| | - L G Lacerenza
- Department of Pharmaceutical Medicine, Azienda USL Toscana Sud-Est, "Misericordia" Hospital, Grosseto, Italy
| | - M Gabriele
- Respiratory Unit, department of Experimental Medicine, University of Rome "Tor Vergata" Rome, Italy
| | - D Radovanovic
- Department of Biomedical and Clinical Sciences (DIBIC), Università Degli Studi di Milano, Division of Pulmonary Diseases, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco, Milan, Italy
| | - A Perrella
- Pneumology Department, Azienda USL Toscana Sud-Est, "Misericordia" Hospital, Grosseto, Italy
| | - P Rogliani
- Respiratory Unit, department of Experimental Medicine, University of Rome "Tor Vergata" Rome, Italy
| | - M Scalese
- Clinic Physiology Institute, National Research Centre, Pisa, Italy
| |
Collapse
|
4
|
Sposato B, Scalese M, Camiciottoli G, Carpagnano GE, Pelaia C, Santus P, Pelaia G, Palmiero G, Di Tomassi M, Ronchi MC, Cameli P, Bargagli E, Ciambellotti L, Rizzello S, Sglavo R, Coppola A, Lacerenza LG, Gabriele M, Radovanovic D, Perrella A, Ricci A, Rogliani P. Severe asthma and long-term Benralizumab effectiveness in real-life. Eur Rev Med Pharmacol Sci 2022; 26:7461-7473. [PMID: 36314316 DOI: 10.26355/eurrev_202210_30016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/31/2023]
Abstract
OBJECTIVE Long-term efficacy of Benralizumab in real life is not clearly known. We assessed the long-term effectiveness persistence to anti-IL-5R treatment in a group of severe eosinophilic asthmatics. PATIENTS AND METHODS We retrospectively analyzed 95 individuals affected by severe asthma (36 males ̶ 37.9%; mean age 58.1 ± 12.2) treated with Benralizumab (mean time 19.7 ± 7.2 months, range 12-35). Outcomes were evaluated at the beginning and at the end of patients' treatment periods. RESULTS Mean baseline blood eosinophils were 897.5 ± 720.1 cells/μL (11 ± 5.6%) decreasing to 7.4 ± 20.6 cells/μL (0.97 ± 0.26%; p < 0.0001) after Benralizumab. FENO likewise decreased from 63.9 ± 68.4 to 28.4 ± 23.6 ppb, while FEV1% significantly improved (p < 0.0001). Mean FEF25-75 also increased from 45.8 ± 24.6% to 60.7 ± 24.6%, whereas RAW dropped from 202.15 ± 109.6% to 135.2 ± 54.75% (p < 0.0001). Also, lung volumes greatly decreased. ACT/ACQ significantly improved, while exacerbations number fell from 4.1 ± 2.4, before anti-IL-5R, to 0.33 ± 0.77, after treatment (p < 0.0001). Rhinitis severity levels and SNOT-22 also changed favorably. Patients that took long-term OCs were 71.6% before treatment, decreasing to 23.2% after Benralizumab (p < 0.0001), with an OCs dose reduction from 14.8 ± 8.9 to 1.45 ± 2.8 mg/day (p < 0.0001). 51.6% of subjects used SABA as needed before Benralizumab, falling to 4.2% after treatment. Several patients showed a reduction of ICS doses, SABA use and maintenance therapy step-down. Clinical/biological response with anti-IL-5R remained constant or even improved in terms of exacerbations or maintenance therapy reductions over time. On the contrary, FEF25-75% improvement slowed down in the long-term. No relationship was found between baseline blood eosinophil number and therapeutic response. CONCLUSIONS Long-term Benralizumab effectiveness persistence in all outcomes in real life was confirmed.
Collapse
Affiliation(s)
- B Sposato
- Pneumology Department, Azienda USL Toscana Sud-Est, "Misericordia" Hospital, Grosseto, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Gilio M, Quattrocchi M, Giuliano A, Ricci A, Belmonte G, Tofani A. Feasibility study for the realization of individualized 3D printed phantom for dosimetry with accurate Hounsfield units correspondence with real tissues. Phys Med 2021. [DOI: 10.1016/s1120-1797(22)00145-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
6
|
Fedeli L, Belli G, Ciccarone A, Coniglio A, Esposito M, Giannelli M, Sghedoni R, Tarducci R, Altabella L, Belligotti E, Benelli M, Bernardi L, Betti M, Caivano R, Carni M, Chiappiniello A, Cimolai S, Cretti F, Fulcheri C, Gasperi C, Giacometti M, Levrero F, Lizio D, Maieron M, Marzi S, Mascaro L, Mazzocchi S, Meliado G, Morzenti S, Niespolo A, Nocetti L, Noferini L, Oberhofer N, Orsingher L, Quattrocchi M, Ricci A, Savini A, Taddeucci A, Testa C, Tortoli P, Luchinat C, Tenori L, Gobbi G, Gori C, Busoni S, Mazzoni L. Multicenter comparison of MR scanners for quantitative diffusion weighted imaging: apparent diffusion coefficient dependence on acquisition plan and spatial position – preliminary results. Phys Med 2021. [DOI: 10.1016/s1120-1797(22)00475-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
7
|
Tommasino E, Bruno F, Catalucci A, Varrassi M, Sucapane P, Cerone D, Pistoia F, Di Cesare E, Barile A, Ricci A, Marini C, Masciocchi C, Splendiani A. Prognostic value of brain tissues' volumes in patients with essential tremor treated with MRgFUS thalamotomy. J Clin Neurosci 2021; 92:33-38. [PMID: 34509258 DOI: 10.1016/j.jocn.2021.07.051] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2020] [Revised: 06/08/2021] [Accepted: 07/25/2021] [Indexed: 01/05/2023]
Abstract
MRgFUS Vim thalamotomy is a novel, effective, minimally invasive therapeutic option for patients with essential tremor (ET). Among the selection criteria, some parameters related to the patient's anatomy, such as the skull density ratio (SDR), are well recognized. The role of brain tissue interposed between the target and the ultrasound transducers has never been explored. Therefore, the purpose of our study was to evaluate the correlation and the possible predictive value between brain tissue volumes (grey matter - GM, white matter - WM, and cerebrospinal fluid - CSF) and several treatment-related variables (periprocedural parameters, MRI imaging findings, and the clinical outcome). We analysed data from thirty ET patients previously submitted to MRgFUS thalamotomy. Pre-treatment images were automatically segmented in sopra-tentorial (ST) WM, GM, and CSF using SPM 12. The most significant findings were a positive correlation of the ST-GM with the Accumulated Thermal Dose (ATD) (p < 0,001) and a negative correlation of the ATD temperature with ST-CSF and ST-TIV (p < 0,001). Ultrasound propagation speed is lower in fluids than brain tissues. Also, WM has an attenuation rate of 1.5 higher than the GM. Therefore, the difference in the ATD may be explained by the different acoustic properties of normal brain tissues interposed between the transducers and the VIM.
Collapse
Affiliation(s)
- E Tommasino
- Department of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, Italy.
| | - F Bruno
- Department of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, Italy
| | - A Catalucci
- Department of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, Italy
| | - M Varrassi
- Department of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, Italy
| | - P Sucapane
- Neurology Unit, San Salvatore Hospital, L'Aquila, Italy
| | - D Cerone
- Neurology Unit, San Salvatore Hospital, L'Aquila, Italy
| | - F Pistoia
- Department of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, Italy
| | - E Di Cesare
- Department of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, Italy
| | - A Barile
- Department of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, Italy
| | - A Ricci
- Department of Neurosurgery, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, Italy
| | - C Marini
- Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy
| | - C Masciocchi
- Department of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, Italy.
| | - A Splendiani
- Department of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, Italy.
| |
Collapse
|
8
|
Montevecchi G, Masino F, Versari A, Ricci A, Nigro G, Antonelli A. Effect of Kaolin/Defoliation Combined with Dry Ice on Lambrusco Red Wine Production to Constrain the Effects of Climate Change. S AFR J ENOL VITIC 2021. [DOI: 10.21548/42-2-4436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Since viticulture is affected considerably by climate change, it is imperative to encourage research on newstrategies in order to constrain these critical effects on the composition of berries and the quality of wines.A multi-strategy approach composed of (i) kaolin application on foliage, (ii) late tree defoliation and (iii)cryomaceration of grapes with dry ice was evaluated in the production of Lambrusco Salamino wines.Physical, chemical and sensory analyses were carried out on the sample set, including the control wines.In general, cryomaceration with dry ice proved to be a winning choice to lower alcoholic strength (roughly5%). In addition, the wines showed an increase in anthocyanin content by approximately 17%, while thecontent of catechins, flavanols and hydroxycinnamic acids decreased. Consistent with the increase in theanthocyanin content, an increase in colour indices and sensory colour intensity scores was observed. As forthe aromatic profile, 2-phenylethanol showed an increase of approximately 18% in the treated wines while,in parallel, a lower content of C6 alcohols and volatile fatty acids was observed. The multiple adaptationstrategies put in place in the present study show an alternative way to mitigate the severe effects of climatechange on wine production, and to face changing consumer demands.
Collapse
|
9
|
Rizzo A, Frega G, Palloni A, Piemontese A, Di Federico A, Ricci A, Carloni R, Fabbri F, Novelli M, Tavolari S, Di Marco M, Ravaioli M, Brandi G. P-69 Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.05.124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
10
|
Blocken B, van Druenen T, Ricci A, Kang L, van Hooff T, Qin P, Xia L, Ruiz CA, Arts JH, Diepens JFL, Maas GA, Gillmeier SG, Vos SB, Brombacher AC. Ventilation and air cleaning to limit aerosol particle concentrations in a gym during the COVID-19 pandemic. Build Environ 2021; 193:107659. [PMID: 33568882 PMCID: PMC7860965 DOI: 10.1016/j.buildenv.2021.107659] [Citation(s) in RCA: 51] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/25/2020] [Revised: 01/28/2021] [Accepted: 01/31/2021] [Indexed: 05/03/2023]
Abstract
SARS-CoV-2 can spread by close contact through large droplet spray and indirect contact via contaminated objects. There is mounting evidence that it can also be transmitted by inhalation of infected saliva aerosol particles. These particles are generated when breathing, talking, laughing, coughing or sneezing. It can be assumed that aerosol particle concentrations should be kept low in order to minimize the potential risk of airborne virus transmission. This paper presents measurements of aerosol particle concentrations in a gym, where saliva aerosol production is pronounced. 35 test persons performed physical exercise and aerosol particle concentrations, CO2 concentrations, air temperature and relative humidity were obtained in the room of 886 m³. A separate test was used to discriminate between human endogenous and exogenous aerosol particles. Aerosol particle removal by mechanical ventilation and mobile air cleaning units was measured. The gym test showed that ventilation with air-change rate ACH = 2.2 h-1, i.e. 4.5 times the minimum of the Dutch Building Code, was insufficient to stop the significant aerosol concentration rise over 30 min. Air cleaning alone with ACH = 1.39 h-1 had a similar effect as ventilation alone. Simplified mathematical models were engaged to provide further insight into ventilation, air cleaning and deposition. It was shown that combining the above-mentioned ventilation and air cleaning can reduce aerosol particle concentrations with 80 to 90% , depending on aerosol size. This combination of existing ventilation supplemented with air cleaning is energy efficient and can also be applied for other indoor environments.
Collapse
Affiliation(s)
- B Blocken
- Unit Building Physics and Services, Department of the Built Environment, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
- Building Physics and Sustainable Design, Department of Civil Engineering, KU Leuven, Kasteelpark Arenberg 40 - Bus 2447, 3001, Leuven, Belgium
| | - T van Druenen
- Unit Building Physics and Services, Department of the Built Environment, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
| | - A Ricci
- Unit Building Physics and Services, Department of the Built Environment, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
- Building Physics and Sustainable Design, Department of Civil Engineering, KU Leuven, Kasteelpark Arenberg 40 - Bus 2447, 3001, Leuven, Belgium
- Department of Civil, Chemical and Environmental Engineering, University of Genoa, Genoa, Italy
| | - L Kang
- Unit Building Physics and Services, Department of the Built Environment, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
| | - T van Hooff
- Unit Building Physics and Services, Department of the Built Environment, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
| | - P Qin
- Unit Building Physics and Services, Department of the Built Environment, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
| | - L Xia
- Unit Building Physics and Services, Department of the Built Environment, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
| | - C Alanis Ruiz
- Building Physics and Sustainable Design, Department of Civil Engineering, KU Leuven, Kasteelpark Arenberg 40 - Bus 2447, 3001, Leuven, Belgium
| | - J H Arts
- Department of Industrial Design, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
- School of Sport Studies, Fontys University of Applied Sciences, Theo Koomenlaan 3, 5644HZ Eindhoven, the Netherlands
| | - J F L Diepens
- Unit Building Physics and Services, Department of the Built Environment, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
| | - G A Maas
- Unit Building Physics and Services, Department of the Built Environment, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
| | - S G Gillmeier
- Unit Building Physics and Services, Department of the Built Environment, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
| | - S B Vos
- Department of Industrial Design, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
- School of Sport Studies, Fontys University of Applied Sciences, Theo Koomenlaan 3, 5644HZ Eindhoven, the Netherlands
| | - A C Brombacher
- Department of Industrial Design, Eindhoven University of Technology, P.O. Box 513, 5600MB Eindhoven, the Netherlands
| |
Collapse
|
11
|
Gallorini M, Di Carlo R, Pilato S, Ricci A, Schweikl H, Cataldi A, Fontana A, Zara S. Liposomes embedded with differentiating factors as a new strategy for enhancing DPSC osteogenic commitment. Eur Cell Mater 2021; 41:108-120. [PMID: 33501637 DOI: 10.22203/ecm.v041a08] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Human dental pulp stem cell (DPSC) differentiation toward the osteoblastic phenotype is enhanced when culture media are supplemented with differentiating factors, i.e. ascorbic acid, β-glycerophosphate and dexamethasone. Liposomes, spherical vesicles formed by a phospholipid bilayer, are frequently used as carriers for drugs, growth factors and hydrophobic molecules. The aim of this work was to speed up DPSC commitment to the osteogenic lineage by embedding differentiating factors within liposomes. Firstly, liposomes were prepared by rehydrating a phospholipidic thin film and characterised in terms of dimensions. Secondly, liposome-exposed DPSCs were characterised by their immunophenotypic profile. Levels of CD90 were significantly decreased in the presence of liposomes filled with ascorbic acid, β-glycerophosphate and dexamethasone (Lipo-Mix) with respect to normal differentiation medium (DM), while CD73 and CD29 expression were enhanced, suggesting osteogenic commitment. Additionally, an appreciable extracellular matrix deposition is detected. Thirdly, the Lipo-Mix formulation better increases alkaline phosphatase activity and levels of Collagen I secretion with respect to DM. In parallel, the new liposome formulation is capable of decreasing the release of H2O2 and of triggering a precocious antioxidant cell response, redressing the redox balance required upon mesenchymal stem cell commitment to osteogenesis. It can be therefore hypothesised that Lipo-Mix could represent a suitable tool for clinical regenerative purposes in the field of tissue engineering by speeding up DPSC osteogenic commitment, mineralised matrix deposition and remodelling.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | - S Zara
- University "G. d'Annunzio" Chieti-Pescara, 66100, Chieti,
| |
Collapse
|
12
|
D'ascanio M, Innammorato M, Pasquariello L, Pizzirusso D, Guerrieri G, Castelli S, Pezzuto A, De Vitis C, Anibaldi P, Marcolongo A, Mancini R, Ricci A, Sciacchitano S. Age is not the only risk factor in COVID-19: the role of comorbidities and of long staying in residential care homes. BMC Geriatr 2021; 21:63. [PMID: 33451296 PMCID: PMC7809533 DOI: 10.1186/s12877-021-02013-3] [Citation(s) in RCA: 38] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2020] [Accepted: 01/06/2021] [Indexed: 02/08/2023] Open
Abstract
BACKGROUND The actual SARS-CoV-2 outbreak caused a highly transmissible disease with a tremendous impact on elderly people. So far, few studies focused on very elderly patients (over 80 years old). In this study we examined the clinical presentation and the outcome of the disease in this group of patients, admitted to our Hospital in Rome. METHODS This is a single-center, retrospective study performed in the Sant'Andrea University Hospital of Rome. We included patients older than 65 years of age with a diagnosis of COVID-19, from March 2020 to May 2020, divided in two groups according to their age (Elderly: 65-80 years old; Very Elderly > 80 years old). Data extracted from the each patient record included age, sex, comorbidities, symptoms at onset, the Pneumonia Severity Index (PSI), the ratio of the partial pressure of oxygen in arterial blood (PaO2) to the inspired oxygen fraction (FiO2) (P/F) on admission, laboratory tests, radiological findings on computer tomography (CT), length of hospital stay (LOS), mortality rate and the viral shedding. The differences between the two groups were analyzed by the Fisher's exact test or the Wilcoxon signed-rank test for categorical variables and the Mann-Whitney U test for continuous variables. To assess significance among multiple groups of factors, we used the Bonferroni correction. The survival time was estimated by Kaplan-Meier method and Log Rank Test. Univariate and Multivariate logistic regression were performed to estimate associations between age, comorbidities, provenance from long-stay residential care homes (LSRCH) s and clinical outcomes. RESULTS We found that Very Elderly patients had an increased mortality rate, also due to the frequent occurrence of multiple comorbidities. Moreover, we found that patients coming from LSRCHs appeared to be highly susceptible and vulnerable to develop severe manifestations of the disease. CONCLUSION We demonstrate that there were considerable differences between Elderly and Very Elderly patients in terms of inflammatory activity, severity of disease, adverse clinical outcomes. To establish a correct risk stratification, comorbidities and information about provenience from LSRCHs should be considered.
Collapse
Affiliation(s)
- M D'ascanio
- Division of Pneumology, Sant'Andrea Hospital, Via di Grottarossa, 1035-1039, 00189, Rome, Italy.
| | - M Innammorato
- Division of Pneumology, Sant'Andrea Hospital, Via di Grottarossa, 1035-1039, 00189, Rome, Italy
- Department of Clinical and Molecular Medicine, Sapienza University, Viale Regina Elena n. 324, 00161, Rome, Italy
| | - L Pasquariello
- Division of Pneumology, Sant'Andrea Hospital, Via di Grottarossa, 1035-1039, 00189, Rome, Italy
- Department of Clinical and Molecular Medicine, Sapienza University, Viale Regina Elena n. 324, 00161, Rome, Italy
| | - D Pizzirusso
- Department of Clinical and Molecular Medicine, Sapienza University, Viale Regina Elena n. 324, 00161, Rome, Italy
| | - G Guerrieri
- Department of Clinical and Molecular Medicine, Sapienza University, Viale Regina Elena n. 324, 00161, Rome, Italy
| | - S Castelli
- Department of Clinical and Molecular Medicine, Sapienza University, Viale Regina Elena n. 324, 00161, Rome, Italy
| | - A Pezzuto
- Division of Pneumology, Sant'Andrea Hospital, Via di Grottarossa, 1035-1039, 00189, Rome, Italy
| | - C De Vitis
- Department of Clinical and Molecular Medicine, Sapienza University, Viale Regina Elena n. 324, 00161, Rome, Italy
| | - P Anibaldi
- Health Director, Sant'Andrea Hospital, Via di Grottarossa, 1035-1039, 00189, Rome, Italy
| | - A Marcolongo
- General Director, Sant'Andrea Hospital, Via di Grottarossa, 1035-1039, 00189, Rome, Italy
| | - R Mancini
- Department of Clinical and Molecular Medicine, Sapienza University, Viale Regina Elena n. 324, 00161, Rome, Italy
| | - A Ricci
- Department of Clinical and Molecular Medicine, Sapienza University, Viale Regina Elena n. 324, 00161, Rome, Italy
| | - S Sciacchitano
- Department of Clinical and Molecular Medicine, Sapienza University, Viale Regina Elena n. 324, 00161, Rome, Italy
- Laboratory of Biomedical research, Niccolò Cusano University Foundation, Via Don Carlo Gnocchi, 3, 00166, Rome, Italy
| |
Collapse
|
13
|
Nanni A, Ricci A, Versari A, Messori M. Wine derived additives as poly(butylene succinate) (PBS) natural stabilizers for different degradative environments. Polym Degrad Stab 2020. [DOI: 10.1016/j.polymdegradstab.2020.109381] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Camerini A, Del Conte A, Pezzuto A, Scotti V, Facchinetti F, Ciccone L, Perna M, Sartori G, Puccetti C, Ricci A, Santo A, Tiseo M, Amoroso D. 412P Treatment patterns and selection criteria for advanced non-small cell lung cancer (NSCLC) patients unfit for platinum-based first-line therapy: Results of the MOON-OSS observational trial. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.10.406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
15
|
Sposato B, Scalese M, Camiciottoli G, Carpagnano GE, Pelaia C, Santus P, Maniscalco M, Corsico A, Grosso A, Baglioni S, Murgia N, Folletti I, Pelaia G, Masieri S, Cavaliere C, Musarra A, Bargagli E, Ricci A, Latorre M, Rogliani P, Paggiaro P. Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis. Respir Med Res 2020; 78:100791. [PMID: 33039948 DOI: 10.1016/j.resmer.2020.100791] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2020] [Revised: 08/25/2020] [Accepted: 08/31/2020] [Indexed: 11/16/2022]
Affiliation(s)
- B Sposato
- Azienda USL Toscana Sud-Est Pneumology Department, "Misericordia" Hospital, Grosseto, Italy; Experimental Medicine and Systems, "PhD program" Department of Systems Medicine University of Rome "Tor Vergata", Rome, Italy.
| | - M Scalese
- Clinic Physiology Institute, National Research Centre, Pisa, Italy
| | - G Camiciottoli
- Section of Respiratory Medicine, Department of Experimental and Clinical Medicine, Careggi University Hospital, University of Florence, Largo A Brambilla 3, 50134, Florence, Italy
| | - G E Carpagnano
- Institute of Respiratory Diseases, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - C Pelaia
- Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University "Magna Græcia" of Catanzaro, Catanzaro, Italy
| | - P Santus
- Department of Biomedical and Clinical Sciences (DIBIC), Università Degli Studi di Milano, Division of Pulmonary Diseases, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco, Milan, Italy
| | - M Maniscalco
- Institute Clinici Scientifici Maugeri IRCCS, Respiratory Rehabilitation of the Istitute of Telese, 82037 Telese Terme (BN), Italy
| | - A Corsico
- Division of Respiratory Diseases, IRCCS "San Matteo" Hospital Foundation, University of Pavia, Pavia, Italy
| | - A Grosso
- Division of Respiratory Diseases, IRCCS "San Matteo" Hospital Foundation, University of Pavia, Pavia, Italy
| | - S Baglioni
- Pneumology Department, Perugia Hospital, Perugia, Italy
| | - N Murgia
- Section of Occupational Medicine, Respiratory Diseases and Toxicology, University of Perugia, Perugia, Italy
| | - I Folletti
- Occupational Medicine, Terni Hospital, University of Perugia, Perugia, Italy
| | - G Pelaia
- Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University "Magna Græcia" of Catanzaro, Catanzaro, Italy
| | - S Masieri
- Department of Sense Organs, Otorhinolaryngology Clinic, Policlinico Umberto I, "Sapienza" University, Rome, Italy
| | - C Cavaliere
- Department of Sense Organs, Otorhinolaryngology Clinic, Policlinico Umberto I, "Sapienza" University, Rome, Italy
| | - A Musarra
- Allergology Department, Casa della Salute di Scilla, Scilla, RC, Italy
| | - E Bargagli
- Department of Medicine, Surgery and Neurosciences, Respiratory Diseases and Lung Transplant Unit, University of Siena, Siena, Italy
| | - A Ricci
- Division of Pneumology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, AOU Sant'Andrea, Rome, Italy
| | - M Latorre
- Department of Surgery, Medicine, Molecular Biology and Critical Care, University of Pisa, Pisa, Italy
| | - P Rogliani
- Experimental Medicine and Systems, "PhD program" Department of Systems Medicine University of Rome "Tor Vergata", Rome, Italy; Respiratory Unit, department of Experimental Medicine, University of Rome "Tor Vergata" Rome, Rome, Italy
| | - P Paggiaro
- Department of Surgery, Medicine, Molecular Biology and Critical Care, University of Pisa, Pisa, Italy
| |
Collapse
|
16
|
Giuffre G, Sisti LG, Ricci A. FRESHER and RARE 2030: scanning the horizon emerging trends in health and healthcare. Eur J Public Health 2020. [DOI: 10.1093/eurpub/ckaa165.182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Health and healthcare are facing novel challenges ranging from broad, shifting trends to emerging innovative technologies and social practices. Foresight methodology aims to analyse emerging trends, building different future scenarios and identifying policy options to support the policy dialogue.
Methods
FRESHER and RARE 2030 are two EU-H2020 projects. FRESHER- FoRESight for hEalth policy development and Regulation (2016-2018) aimed at representing long term alternative health Scenarios testing future policies to tackle the burden of Non-Communicable Diseases. A micro-simulation model, specifically enhanced by the project, also computed the health outcomes of the different four Scenarios. Rare 2030-Foresight in Rare Diseases Policy (2019-2020) uses a participatory approach to identify the most relevant trends, anticipate their influence over the next decade and propose policy recommendations that could lead to a better future for people living with Rare Diseases. Different in scope, these projects share common features. Both follow a four steps foresight methodology: horizon scanning, trends identification and ranking, scenarios building, back-casting and policy elaboration. Taking a participatory approach, these studies apply structured qualitative tools, involve a wide range of stakeholders and include regional case studies.
Results
20 trends emerged as key for the future of health and healthcare, among them: demographic change, rise of inequality, urbanisation, climate change and low carbon development, innovation in medicine, citizens empowerment and the potential for big data and Artificial Intelligence application.
Conclusions
The 20 trends analysed offering a litmus test for future proofing current health and healthcare policies. Foresight has proven to be a valid methodology to gather collective intelligence for identifying emerging trends and scenarios, evaluating risks and opportunities, setting long term goals and helping the decision making in health.
Key messages
To promote a transition toward better health policies, it is crucial supporting the collaborative attitude and ensuring a greater involvement of citizens and patients in the decision making. The importance and unpredictability recognized to the equity trend in both projects reveals the need for urgent actions to ensure the future access to better health and care to all European citizens.
Collapse
Affiliation(s)
- G Giuffre
- ISINNOVA, Istituto di Studi per l'Integrazione dei Sistemi, Rome, Italy
| | - L G Sisti
- ISINNOVA, Istituto di Studi per l'Integrazione dei Sistemi, Rome, Italy
| | - A Ricci
- ISINNOVA, Istituto di Studi per l'Integrazione dei Sistemi, Rome, Italy
| |
Collapse
|
17
|
Ricci A, Li M, Fricke P, Cabrera V. Corrigendum to “Short communication: Economic impact among 7 reproductive programs for lactating dairy cows, including a sensitivity analysis of the cost of hormonal treatments” (J. Dairy Sci. 103:5654–5661). J Dairy Sci 2020; 103:8708. [DOI: 10.3168/jds.2020-103-9-8708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
18
|
Rizzo A, Ricci A, Frega G, Palloni A, Dall'Olio F, Lorenzo SD, Tavolari S, Abbati F, Vasuri F, Di Marco M, Tober N, Nigro M, Mosca M, Mollica V, Maggio I, Tovoli F, Cescon M, Serra C, Ambrosini V, Nanni C, Fanti S, Brandi G. PD-2 Role of pretreatment SUVmax on 18F-FDG PET and clinicopathological features in the prognostic stratification of newly diagnosed intrahepatic cholangiocarcinoma. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.04.458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
19
|
Terzo F, Pasquariello L, Ricci A. INTRAPLEURAL UROKINASE THERAPY OF EMPYEMA. Chest 2020. [DOI: 10.1016/j.chest.2020.05.216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
20
|
Pezzuto A, Ricci A, Borro M, Guerrini S, Guerrieri G, Lionetto L. THE INFLUENCE OF NICOTINE METABOLISM RATE AND SMOKING HABIT ON COPD DEVELOPMENT: A RETROSPECTIVE STUDY. Chest 2020. [DOI: 10.1016/j.chest.2020.05.498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
21
|
Ricci A, Fang J, He F, Cain P, Calhoun SL, Liao D, Vgontzas AN, Bixler EO, Fernandez-Mendoza J. 0319 Sleep Architecture and Neurocognitive and Behavioral Functioning in Youth from the General Population. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
The transition from childhood to adolescence is critical for the onset of psychopathology and reflects significant changes in the sleeping brain. Sleep deprivation studies have shown that rapid eye movement (REM) and non-rapid eye movement (NREM) sleep are differentially involved in specific cognitive functions. The aim of this study was to examine the association of sleep architecture with neurobehavioral outcomes in a population-based sample.
Methods
We studied 700 children (5-12y, 47.1% female, 23.7% minority) and 421 adolescents (12-23y, 46.1% female, 21.8% minority) from the Penn State Child Cohort. All subjects underwent a 9-hour polysomnography and a 4-hour neurobehavioral evaluation. Neurocognitive outcomes included the Stroop test, digit span backwards (DSB), and coding to measure high- and low-order cognitive functions. Behavioral outcomes included the Child/Adult Behavior Checklist to measure internalizing symptoms and externalizing behaviors. Correlation analysis examined the cross-sectional association between sleep architecture and neurocognitive and behavioral outcomes.
Results
In childhood, %REM sleep was negatively associated with DSB scores (r=-0.088, p=0.027), particularly in males (r=-0.167, p=0.002). Furthermore, %NREM sleep was positively associated with DSB scores in males (r=0.126, p=0.021). In adolescent females, %NREM and %REM sleep were positively (r=0.146, p=0.044) and negatively (r=-0.158, p=0.029) associated with DSB scores, respectively. In adolescence, %NREM sleep was negatively associated with internalizing symptoms (r=-0.109, p=0.026).
Conclusion
Male children and female adolescents who spent a higher proportion of the night in NREM sleep had better working memory performance. Adolescent females who spent a lower proportion of the night in NREM sleep had greater internalizing symptoms. This study suggests a role for sleep architecture in neurobehavioral deficits in youth. Future studies are necessary to determine the contributions of low- and high-frequency sleep EEG dynamics to these clinical outcomes.
Support
National Institutes of Health (R01MH118308, R01HL97165, R01HL63772, UL1TR000127)
Collapse
Affiliation(s)
- A Ricci
- Penn State College of Medicine, Hershey, PA
| | - J Fang
- Penn State College of Medicine, Hershey, PA
| | - F He
- Penn State College of Medicine, Hershey, PA
| | - P Cain
- Penn State College of Medicine, Hershey, PA
| | | | - D Liao
- Penn State College of Medicine, Hershey, PA
| | | | - E O Bixler
- Penn State College of Medicine, Hershey, PA
| | | |
Collapse
|
22
|
Ferrazzano L, Martelli G, Fantoni T, Daka A, Corbisiero D, Viola A, Ricci A, Cabri W, Tolomelli A. Fast Heck-Cassar-Sonogashira (HCS) Reactions in Green Solvents. Org Lett 2020; 22:3969-3973. [PMID: 32342693 PMCID: PMC8007125 DOI: 10.1021/acs.orglett.0c01269] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
![]()
The replacement of
toxic solvents with greener alternatives in
Heck–Cassar–Sonogashira (HCS) cross-couplings was investigated.
The fine-tuning of the HCS protocol allowed to achieve complete conversions
and high speed under mild conditions. N-Hydroxyethylpyrrolidone
(HEP) gave the best results. Moreover, the methodology was successfully
applied to the synthesis of an intermediate of the anticancer drug
Erlotinib, demonstrating the versatility of the new green protocol.
Collapse
Affiliation(s)
- L Ferrazzano
- Department of Chemistry "G. Ciamician", Alma Mater Studiorum-University of Bologna, Via Selmi 2, 40126 Bologna, Italy
| | - G Martelli
- Department of Chemistry "G. Ciamician", Alma Mater Studiorum-University of Bologna, Via Selmi 2, 40126 Bologna, Italy
| | - T Fantoni
- Department of Chemistry "G. Ciamician", Alma Mater Studiorum-University of Bologna, Via Selmi 2, 40126 Bologna, Italy
| | - A Daka
- Department of Chemistry "G. Ciamician", Alma Mater Studiorum-University of Bologna, Via Selmi 2, 40126 Bologna, Italy
| | - D Corbisiero
- Department of Chemistry "G. Ciamician", Alma Mater Studiorum-University of Bologna, Via Selmi 2, 40126 Bologna, Italy
| | - A Viola
- Fresenius Kabi iPSUM Srl, I&D, Via San Leonardo 23, 45010 Villadose (RO), Italy
| | - A Ricci
- Fresenius Kabi iPSUM Srl, I&D, Via San Leonardo 23, 45010 Villadose (RO), Italy
| | - W Cabri
- Department of Chemistry "G. Ciamician", Alma Mater Studiorum-University of Bologna, Via Selmi 2, 40126 Bologna, Italy.,Fresenius Kabi iPSUM Srl, I&D, Via San Leonardo 23, 45010 Villadose (RO), Italy
| | - A Tolomelli
- Department of Chemistry "G. Ciamician", Alma Mater Studiorum-University of Bologna, Via Selmi 2, 40126 Bologna, Italy
| |
Collapse
|
23
|
Ricci A, Li M, Fricke PM, Cabrera VE. Short communication: Economic impact among 7 reproductive programs for lactating dairy cows, including a sensitivity analysis of the cost of hormonal treatments. J Dairy Sci 2020; 103:5654-5661. [PMID: 32307172 DOI: 10.3168/jds.2019-17658] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2019] [Accepted: 02/03/2020] [Indexed: 11/19/2022]
Abstract
Although hormonal synchronization programs can improve reproductive efficiency of dairy herds, some farmers question the economics of these programs based on the upfront cost of hormonal treatments as opposed to the economic value of the resulting reproductive performance. Our aim was to compare the economic impact of reproductive management programs that incorporate varying degrees of detection of estrus and timed artificial insemination (AI) in dairy herds with year-round calving in confinement total mixed ration systems. A reproductive economic analysis simulation model was used to compare the economic impact of pairs of reproductive management programs. We simulated sets of scenarios for 2 analyses. In the first analysis, we calculated the economic impact of switching from a Presynch-Ovsynch program to a Double-Ovsynch program that included a second PGF2α treatment during the Breeding-Ovsynch portion of the program (Double-Ovsynch+PGF). In the second analysis, we conducted a break-even analysis in which the cost of hormonal treatments was incrementally increased within various reproductive management programs. Our analyses revealed that a Double-Ovsynch+PGF program, the most intensive program evaluated, was more profitable than other programs compared, including a Presynch-Ovsynch program with 100% timed AI or a Presynch-Ovsynch program that incorporated detection of estrus, despite the higher upfront cost incurred by using more hormonal treatments. This advantage remained until the cost of hormones was increased 5 to 14 times current US market prices and 2 to 6 times current European market prices. The cost of GnRH had a greater impact on net profit gain than the cost of PGF2α. In conclusion, more intensive reproductive programs that use more hormonal treatments but result in substantially increased reproductive performance are more profitable than less intensive programs and remain so even if hormone prices are unusually high.
Collapse
Affiliation(s)
- A Ricci
- Department of Veterinary Science, University of Torino, 10095, Grugliasco, Italy
| | - M Li
- Department of Dairy Science, University of Wisconsin-Madison, Madison 53705
| | - P M Fricke
- Department of Dairy Science, University of Wisconsin-Madison, Madison 53705
| | - V E Cabrera
- Department of Dairy Science, University of Wisconsin-Madison, Madison 53705.
| |
Collapse
|
24
|
Genova C, Rossi G, Pezzuto A, Valmadre G, Rijavec E, Biello F, Barletta G, Tagliamento M, Bello MD, Boccardo S, Coco S, Alama A, Sini C, Burrafato G, Maggioni C, Bennicelli E, Cerbone L, Zullo L, Ricci A, Grossi F. P2.14-02 Interim Survival Analysis of Gefitinib Plus Vinorelbine in Advanced EGFR-Mutant Non-Small Cell Lung Cancer (Genoa Trial). J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1787] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
25
|
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Matucci A, Vultaggio A, Ricci A, Cresti A, Paggiaro PL. Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma. J Investig Allergol Clin Immunol 2019; 27:388-391. [PMID: 29199967 DOI: 10.18176/jiaci.0196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- B Sposato
- Pneumology Department, Misericordia Hospital, Grosseto, Italy
| | - M Scalese
- Institute of Clinical Phisiology, CNR, Pisa, Italy
| | - M Milanese
- Pneumology Department, S.Corona Hospital, Pietra Ligure, Italy
| | - S Masieri
- Otorhinolaryngology Clinic, Policlinico Umberto I, "Sapienza" University, Rome, Italy
| | - C Cavaliere
- Otorhinolaryngology Clinic, Policlinico Umberto I, "Sapienza" University, Rome, Italy
| | - M Latorre
- Cardio Thoracic and Vascular Department, Pathophysiology Unit, University of Pisa, Pisa, Italy
| | - N Scichilone
- DIMPEFINU, Unit of Pneumology and Medicine, University of Palermo, Palermo, Italy
| | - A Matucci
- Immunoallergology Unit, Department of Medicine and Geriatric, AOU Careggi, Florence, Italy
| | - A Vultaggio
- Immunoallergology Unit, Department of Medicine and Geriatric, AOU Careggi, Florence, Italy
| | - A Ricci
- Division of Pneumology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, AOU Sant´Andrea, Rome, Italy
| | - A Cresti
- Cardiology Department, Misericordia Hospital, Grosseto, Italy
| | - P L Paggiaro
- Cardio Thoracic and Vascular Department, Pathophysiology Unit, University of Pisa, Pisa, Italy
| |
Collapse
|
26
|
Ricci A, Burlando M, Repetto MP, Blocken B. Simulation of urban boundary and canopy layer flows in port areas induced by different marine boundary layer inflow conditions. Sci Total Environ 2019; 670:876-892. [PMID: 30921720 DOI: 10.1016/j.scitotenv.2019.03.230] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/11/2019] [Revised: 02/28/2019] [Accepted: 03/15/2019] [Indexed: 05/21/2023]
Abstract
Computational fluid dynamics (CFD) simulations and wind-tunnel (WT) tests can be considered as boundary-value problems, where the inlet boundary condition, which is usually obtained inferring inlet mean wind profiles from on-site measurements or other type of experimental data, represents the large-scale atmospheric forcing exerted at the outer limit of the urban model. It is not clear, however, to which extent the choice of different inflow wind speed profiles may affect WT and CFD results in the urban environment. In the present study, this aspect is investigated through the comparison of the wind flow fields simulated numerically and tested experimentally in an atmospheric boundary layer wind tunnel (ABLWT) within a district of Livorno city, Italy, called "Quartiere La Venezia". Three different shapes of inflow profiles were tested using the CFD technique and the results were compared with each other: one is based on the approach-flow profiles measured upstream of the urban model in the WT test section (WT profile) and two are based on anemometric data corresponding to the approach-flow profile measured by means of a LiDAR wind profiler (LiDAR profile 1 and 2). The analysis showed that using different wind speed profiles does not affect significantly the results in the urban canopy layer (UCL), where correlations of 95% and 98% were found between the LiDAR profile 1 and 2 data and the WT profile data (at z = 0.02 m above the bottom), respectively. Conversely, the different inflow profiles strongly affected the results above the UCL. This means that the local-scale effects induced on the wind field in the UCL by the urban texture are dominated mainly by the larger-scale forcing, as within the canopy the flow remains topologically invariant despite the different inflow conditions.
Collapse
Affiliation(s)
- A Ricci
- Department of Civil Engineering, KU Leuven, Leuven, Belgium; Department of the Built Environment, Eindhoven University of Technology, Eindhoven, the Netherlands; Department of Civil, Chemical and Environmental Engineering (DICCA), University of Genoa, Genoa, Italy.
| | - M Burlando
- Department of Civil, Chemical and Environmental Engineering (DICCA), University of Genoa, Genoa, Italy.
| | - M P Repetto
- Department of Civil, Chemical and Environmental Engineering (DICCA), University of Genoa, Genoa, Italy.
| | - B Blocken
- Department of Civil Engineering, KU Leuven, Leuven, Belgium; Department of the Built Environment, Eindhoven University of Technology, Eindhoven, the Netherlands.
| |
Collapse
|
27
|
Venturi S, Tassi F, Magi F, Cabassi J, Ricci A, Capecchiacci F, Caponi C, Nisi B, Vaselli O. Carbon isotopic signature of interstitial soil gases reveals the potential role of ecosystems in mitigating geogenic greenhouse gas emissions: Case studies from hydrothermal systems in Italy. Sci Total Environ 2019; 655:887-898. [PMID: 30481715 DOI: 10.1016/j.scitotenv.2018.11.293] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/13/2018] [Revised: 11/18/2018] [Accepted: 11/20/2018] [Indexed: 05/02/2023]
Abstract
Volcanic and hydrothermal areas largely contribute to the natural emission of greenhouse gases to the atmosphere, although large uncertainties in estimating their global output still remain. Nevertheless, CO2 and CH4 discharged from hydrothermal fluid reservoirs may support active soil microbial communities. Such secondary processes can control and reduce the flux of these gases to the atmosphere. In order to evaluate the effects deriving from the presence of microbial activity, chemical and carbon (in CO2 and CH4) isotopic composition of interstitial soil gases, as well as diffuse CO2 fluxes, of three hydrothermal systems from Italy were investigated, i.e. (i) Solfatara crater (Campi Flegrei), (ii) Monterotondo Marittimo (Larderello geothermal field) and (iii) Baia di Levante in Vulcano Island (Aeolian Archipelago), where soil CO2 fluxes up to 2400, 1920 and 346 g m-2 day-1 were measured, respectively. Despite the large supply of hydrothermal fluids, 13CO2 enrichments were observed in interstitial soil gases with respect to the fumarolic gas discharges, pointing to the occurrence of autotrophic CO2 fixation processes during the migration of deep-sourced fluids towards the soil-air interface. On the other hand, (i) the δ13C-CH4 values (up to ~48‰ vs. V-PDB higher than those measured at the fumarolic emissions) of the interstitial soil gases and (ii) the comparison of the CO2/CH4 ratios between soil gases and fumarolic emissions suggested that the deep-sourced CH4 was partly consumed by methanotrophic activity, as supported by isotope fractionation modeling. These findings confirmed the key role that methanotrophs play in mitigating the release of geogenic greenhouse gases from volcanic and hydrothermal environments.
Collapse
Affiliation(s)
- S Venturi
- Institute of Geosciences and Earth Resources (IGG), National Research Council of Italy (CNR), Via G. La Pira 4, 50121 Florence, Italy.
| | - F Tassi
- Institute of Geosciences and Earth Resources (IGG), National Research Council of Italy (CNR), Via G. La Pira 4, 50121 Florence, Italy; Department of Earth Sciences, University of Florence, Via G. La Pira 4, 50121 Florence, Italy.
| | - F Magi
- Department of Earth Sciences, University of Florence, Via G. La Pira 4, 50121 Florence, Italy.
| | - J Cabassi
- Institute of Geosciences and Earth Resources (IGG), National Research Council of Italy (CNR), Via G. La Pira 4, 50121 Florence, Italy.
| | - A Ricci
- Department of Biological, Geological and Environmental Sciences, University of Bologna, Porta S. Donato 1, 40127 Bologna, Italy.
| | - F Capecchiacci
- Department of Earth Sciences, University of Florence, Via G. La Pira 4, 50121 Florence, Italy.
| | - C Caponi
- Department of Earth Sciences, University of Florence, Via G. La Pira 4, 50121 Florence, Italy.
| | - B Nisi
- Institute of Geosciences and Earth Resources (IGG), National Research Council of Italy (CNR), Via G. Moruzzi 1, 56124 Pisa, Italy.
| | - O Vaselli
- Institute of Geosciences and Earth Resources (IGG), National Research Council of Italy (CNR), Via G. La Pira 4, 50121 Florence, Italy; Department of Earth Sciences, University of Florence, Via G. La Pira 4, 50121 Florence, Italy.
| |
Collapse
|
28
|
Sabbadini S, Capriotti L, Molesini B, Pandolfini T, Navacchi O, Limera C, Ricci A, Mezzetti B. Comparison of regeneration capacity and Agrobacterium-mediated cell transformation efficiency of different cultivars and rootstocks of Vitis spp. via organogenesis. Sci Rep 2019; 9:582. [PMID: 30679725 PMCID: PMC6345860 DOI: 10.1038/s41598-018-37335-7] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2018] [Accepted: 11/30/2018] [Indexed: 12/20/2022] Open
Abstract
The success of in vitro plant regeneration and the competence of genetic transformation greatly depends on the genotype of the species of interest. In previous work, we developed a method for the efficient Agrobacterium-mediated genetic transformation via organogenesis of V. vinifera cultivar Thompson Seedless, by using meristematic bulk (MB) as starting tissue. In this study, we applied this method for the regeneration and transformation of MBs obtained from the Italian cultivar Ciliegiolo and two of the commonly used Vitis rootstocks, 110 Richter and Kober 5BB, in comparison with Thompson Seedless. The A. tumefaciens strain EHA105, harbouring pK7WG2 binary vector, was used for the transformation trials, which allowed selection through the enhanced-green fluorescent protein (eGFP) and the neomycin phosphotransferase (nptII) gene. Putative transformed tissues and/or shoots were identified by either a screening based on the eGFP expression alone or its use in combination with kanamycin in the medium. MBs obtained from Thompson Seedless showed the highest regeneration and transformation cell competence, which subsequently allowed the recovery of stably transformed plants. Ciliegiolo, 110 Richter, and Kober 5BB, produced actively growing transgenic calli showing eGFP fluorescence, more consistently on selective media, but had no regenerative competence.
Collapse
Affiliation(s)
- S Sabbadini
- Department of Agricultural, Food and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy
| | - L Capriotti
- Department of Agricultural, Food and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy
| | - B Molesini
- Department of Biotechnology, University of Verona, Verona, Italy
| | - T Pandolfini
- Department of Biotechnology, University of Verona, Verona, Italy
| | | | - C Limera
- Department of Agricultural, Food and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy
| | - A Ricci
- Department of Agricultural, Food and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy
| | - B Mezzetti
- Department of Agricultural, Food and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy.
| |
Collapse
|
29
|
Fait MJG, Ricci A, Holena M, Rabeah J, Pohl MM, Linke D, Kondratenko EV. Understanding trends in methane oxidation to formaldehyde: statistical analysis of literature data and based hereon experiments. Catal Sci Technol 2019. [DOI: 10.1039/c9cy01055f] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A regression tree analysis on selective oxidation of methane to methanol/formaldehyde was applied to identify fundamentals affecting catalyst performance. The electronegativity correlates with methane activation energy and formaldehyde selectivity.
Collapse
Affiliation(s)
- M. J. G. Fait
- Leibniz-Institut für Katalyse e.V
- D-18059 Rostock
- Germany
| | - A. Ricci
- Leibniz-Institut für Katalyse e.V
- D-18059 Rostock
- Germany
| | - M. Holena
- Leibniz-Institut für Katalyse e.V
- D-18059 Rostock
- Germany
| | - J. Rabeah
- Leibniz-Institut für Katalyse e.V
- D-18059 Rostock
- Germany
| | - M.-M. Pohl
- Leibniz-Institut für Katalyse e.V
- D-18059 Rostock
- Germany
| | - D. Linke
- Leibniz-Institut für Katalyse e.V
- D-18059 Rostock
- Germany
| | | |
Collapse
|
30
|
Coniglio A, Fedeli L, Belli G, Ciccarone A, Esposito M, Giannelli M, Gobbi G, Gori C, Mazzoni L, Nocetti L, Sghedoni R, Tarducci R, Altabella L, Belligotti E, Benelli M, Betti M, Caivano R, Carnì M, Chiappiniello A, Cimolai S, Cretti F, Fulcheri C, Gasperi C, Giacometti M, Levrero F, Lizio D, Luchinat C, Maieron M, Marzi S, Mascaro L, Mazzocchi S, Meliadò G, Morzenti S, Noferini L, Oberhofer N, Quattrocchi M, Ricci A, Taddeucci A, Tenori L, Torresin A, Busoni S. 20. Diffusion MRI and ADC accuracy at the isocenter: An AIFM multisite comparison study. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
31
|
Fedeli L, Belli G, Ciccarone A, Coniglio A, Esposito M, Giannelli M, Gobbi G, Gori C, Mazzoni L, Nocetti L, Sghedoni R, Tarducci R, Altabella L, Belligotti E, Benelli M, Betti M, Caivano R, Carnì M, Chiappiniello A, Cimolai S, Cretti F, Fulcheri C, Gasperi C, Giacometti M, Levrero F, Lizio D, Luchinat C, Maieron M, Marzi S, Mascaro L, Mazzocchi S, Meliadò G, Morzenti S, Noferini L, Oberhofer N, Quattrocchi M, Ricci A, Taddeucci A, Tenori L, Torresin A, Busoni S. 21 Phase encoding direction and position effects on ADC in diffusion MRI: An AFIM multisite comparison study. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
32
|
Camerini A, Banna GL, Cinieri S, Pezzuto A, Mencoboni M, Rosetti F, Figueiredo A, Rizzo P, Ricci A, Langenhoven L, Santo A, Addeo A, Amoroso D, Barata F. Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis. Clin Transl Oncol 2018; 21:790-795. [PMID: 30448956 DOI: 10.1007/s12094-018-1989-y] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2018] [Accepted: 11/09/2018] [Indexed: 01/14/2023]
Abstract
PURPOSE Metronomic oral vinorelbine (MOV) could be a treatment option for unfit patients with advanced non-small cell lung cancer (NSCLC) based on its safety profile and high patient compliance. METHODS We retrospectively collected data on 270 patients [median age 76 (range 48-92) years, M/F 204/66, PS 0 (27)/1 (110)/≥ 2 (133), median of 3 serious comorbidities] with stage IIIB-IV NSCLC treated with MOV as first (T1) (67%), second (T2) (19%) or subsequent (T3) (14%) line. Schedules consisted of vinorelbine 50 mg (138), 40 mg (68) or 30 mg (64) three times a week continuously. RESULTS Patients received an overall median of 6 (range 1-25) cycles with a total of 1253 cycles delivered. The overall response rate was 17.8% with 46 partial and 2 complete responses and 119 patients (44.1%) experienced stable disease > 12 weeks with an overall disease control rate of 61.9%. Median overall time to progression was 5 (range 1-21) months [T1 7 (1-21), T2 5.5 (1-19) and T3 4 (1-19) months] and median overall survival 9 (range 1-36) months [T1 10 (1-31), T2 8 (1-36) and T3 6.5 (2-29) months]. Treatment was extremely well tolerated with 2% (25/1253) G3/4 toxicity (mainly G3 fatigue and anemia) and no toxic deaths. We observed the longer OS 14 (range 7-36) months in a subset of squamous NSCLC patients receiving immunotherapy after metronomic oral vinorelbine. CONCLUSION We confirmed MOV as an extremely safe treatment in a large real world population of advanced NSCLC with an interesting activity mainly consisting of long-term disease stabilization. We speculate the possibility of a synergistic effect with subsequent immunotherapy.
Collapse
Affiliation(s)
- A Camerini
- Medical Oncology, Versilia Hospital - ASL Toscana Nord-Ovest, via Aurelia 335, 55043, Lido di Camaiore, LU, Italy.
| | - G L Banna
- Division of Medical Oncology, Cannizzaro Hospital, via Messina 829, 95126, Catania, Italy
| | - S Cinieri
- Medical Oncology, Perrino Hospital, Strada Statale 7 per Mesagne, 72100, Brindisi, Italy
| | - A Pezzuto
- Department of Cardio-Thoracic-Vascular Science, S. Andrea Hospital, Via di Grottarossa, 1035, 00189, Rome, Italy
| | - M Mencoboni
- Medical Oncology, ASL 3 Genovese, Ospedale Villa Scassi, Corso Onofrio Scassi 1, 16121, Genoa, Italy
| | - F Rosetti
- Medical Oncology, ULSS3 Serenissima, Distretto Mirano-Dolo, Via Pasteur, 30031, Dolo, VE, Italy
| | - A Figueiredo
- Pneumology, Centro Hospitalar e Universitario de Coimbra, Avenida Doutor Bissaya Barreto S/N, Praceta De Mota Pinto, Celas-Coimbra, Portugal
| | - P Rizzo
- Medical Oncology, Perrino Hospital, Strada Statale 7 per Mesagne, 72100, Brindisi, Italy
| | - A Ricci
- Department of Molecular and Clinical Medicine, S. Andrea Hospital, Via di Grottarossa, 1035, 00189, Rome, Italy
| | - L Langenhoven
- Clinical Oncology, Panorama Oncology Centre, 43 Hennie Winterbach St, Panorama, Cape Town, 7500, South Africa
| | - A Santo
- Medical Oncology, University Hospital of Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy
| | - A Addeo
- Oncology Department, University Hospital Geneva, Rue Gabrielle-Perret-Gentil 4, 1205, Geneva, Switzerland
| | - D Amoroso
- Medical Oncology, Versilia Hospital - ASL Toscana Nord-Ovest, via Aurelia 335, 55043, Lido di Camaiore, LU, Italy
| | - F Barata
- Pneumology, Centro Hospitalar e Universitario de Coimbra, Avenida Doutor Bissaya Barreto S/N, Praceta De Mota Pinto, Celas-Coimbra, Portugal
| |
Collapse
|
33
|
Weltert L, Chirichilli I, D’Aleo S, Guerrieri L, Salica A, Scaffa R, Ricci A, Bellisario A, De Paulis R. EP01 5-YEARS FOLLOW-UP OF AORTIC PROSTHESIS ENDOCARDITIS TREATED USING BIOINTEGRAL CONDUIT. J Cardiovasc Med (Hagerstown) 2018. [DOI: 10.2459/01.jcm.0000550001.22045.ee] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
34
|
Weltert L, D’Aleo S, Chirichilli I, Wolf LG, Ricci A, Scaffa R, Salica A, Bellisario A, De Paulis R. RF09 BEST OF BOTH WORLDS. J Cardiovasc Med (Hagerstown) 2018. [DOI: 10.2459/01.jcm.0000550009.04120.ab] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
35
|
van der Fels-Klerx HJ, Camenzuli L, Belluco S, Meijer N, Ricci A. Food Safety Issues Related to Uses of Insects for Feeds and Foods. Compr Rev Food Sci Food Saf 2018; 17:1172-1183. [DOI: 10.1111/1541-4337.12385] [Citation(s) in RCA: 95] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2018] [Revised: 06/18/2018] [Accepted: 06/22/2018] [Indexed: 11/26/2022]
Affiliation(s)
- H. J. van der Fels-Klerx
- Dept. of Toxicology and Novel Foods; RIKILT Wageningen Research; Akkermaalsbos 2 NL-6708 WB Wageningen The Netherlands
| | - L. Camenzuli
- Dept. of Toxicology and Novel Foods; RIKILT Wageningen Research; Akkermaalsbos 2 NL-6708 WB Wageningen The Netherlands
- ExxonMobile Petroleum & Chemical; Hermeslaan 2 1831 Machelen Belgium
| | - S. Belluco
- Food Safety Dept., Istituto Zooprofilattico Sperimentale delle Venezie; Via dell'Università; 10 35020 Legnaro (PD) Italy
| | - N. Meijer
- Dept. of Toxicology and Novel Foods; RIKILT Wageningen Research; Akkermaalsbos 2 NL-6708 WB Wageningen The Netherlands
| | - A. Ricci
- Food Safety Dept., Istituto Zooprofilattico Sperimentale delle Venezie; Via dell'Università; 10 35020 Legnaro (PD) Italy
| |
Collapse
|
36
|
Cesarone MR, Belcaro G, Rulo A, Griffin M, Ricci A, Ippolito E, De Sanctis MT, Incandela L, Bavera P, Cacchio M, Bucci M. Microcirculatory Effects of Total Triterpenic Fraction of Centella asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-co2, and Leg Volumetry. Angiology 2018. [DOI: 10.1177/000331970105202s09] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The aim of this prospective, randomized study was to demonstrate whether an oral preparation of TTFCA was effective in improving the microcirculation and edema (leg volume) in venous microangiopathy. Forty patients with venous hypertension were included. Treatment was prescribed for 6 weeks (tablets, 60 mg twice daily). Patients were randomized into a treatment and a placebo group. There were 20 patients in each group. In the treatment group the mean age was 42 (SD 7; M:F = 10:10); in the placebo group, the mean age was 40 (SD 9; M:F = 10:10). Tolerability and compliance were very good; there were no dropouts. At inclusion there were no differences between placebo and treatment group. After treatment there was a decrease in resting flux (29%) and an improvement (increase) in venoarteriolar response (52%); PO2 was increased (7.2%) and PCO2 decreased (9.6%). There was an important decrease in leg volume (66 mL decrease; 1.3% volume variation). The difference in flux, O2-CO2 and volume parameters were significant and clinically important at 6 weeks in the treatment group. In conclusion, TTFCA improves microcirculation and leg volume in venous hypertension. The effects of TTFCA are observed even in a limited sample of patients.
Collapse
Affiliation(s)
- M. R. Cesarone
- Irvine2 Vascular Laboratory and Physiology, Department of Biomedical Sciences, Chieti University, San Valentino Vascular Screening Project, Vascular Surgery, University of Milan, General Surgery, Pescara, Physiology Chieti University, Italy
- Irvine Vascular Laboratory, St Mary's Hospital and Imperial College and Vascular Unit, Ealing Hospital, London, UK
| | - G. Belcaro
- Irvine2 Vascular Laboratory and Physiology, Department of Biomedical Sciences, Chieti University, San Valentino Vascular Screening Project, Vascular Surgery, University of Milan, General Surgery, Pescara, Physiology Chieti University, Italy
- Irvine Vascular Laboratory, St Mary's Hospital and Imperial College and Vascular Unit, Ealing Hospital, London, UK
| | - A. Rulo
- Irvine2 Vascular Laboratory and Physiology, Department of Biomedical Sciences, Chieti University, San Valentino Vascular Screening Project, Vascular Surgery, University of Milan, General Surgery, Pescara, Physiology Chieti University, Italy
- Irvine Vascular Laboratory, St Mary's Hospital and Imperial College and Vascular Unit, Ealing Hospital, London, UK
| | - M. Griffin
- Irvine2 Vascular Laboratory and Physiology, Department of Biomedical Sciences, Chieti University, San Valentino Vascular Screening Project, Vascular Surgery, University of Milan, General Surgery, Pescara, Physiology Chieti University, Italy
- Irvine Vascular Laboratory, St Mary's Hospital and Imperial College and Vascular Unit, Ealing Hospital, London, UK
| | - A. Ricci
- Irvine2 Vascular Laboratory and Physiology, Department of Biomedical Sciences, Chieti University, San Valentino Vascular Screening Project, Vascular Surgery, University of Milan, General Surgery, Pescara, Physiology Chieti University, Italy
- Irvine Vascular Laboratory, St Mary's Hospital and Imperial College and Vascular Unit, Ealing Hospital, London, UK
| | - E. Ippolito
- Irvine2 Vascular Laboratory and Physiology, Department of Biomedical Sciences, Chieti University, San Valentino Vascular Screening Project, Vascular Surgery, University of Milan, General Surgery, Pescara, Physiology Chieti University, Italy
- Irvine Vascular Laboratory, St Mary's Hospital and Imperial College and Vascular Unit, Ealing Hospital, London, UK
| | - M. T. De Sanctis
- Irvine2 Vascular Laboratory and Physiology, Department of Biomedical Sciences, Chieti University, San Valentino Vascular Screening Project, Vascular Surgery, University of Milan, General Surgery, Pescara, Physiology Chieti University, Italy
- Irvine Vascular Laboratory, St Mary's Hospital and Imperial College and Vascular Unit, Ealing Hospital, London, UK
| | - L. Incandela
- Irvine2 Vascular Laboratory and Physiology, Department of Biomedical Sciences, Chieti University, San Valentino Vascular Screening Project, Vascular Surgery, University of Milan, General Surgery, Pescara, Physiology Chieti University, Italy
- Irvine Vascular Laboratory, St Mary's Hospital and Imperial College and Vascular Unit, Ealing Hospital, London, UK
| | - P. Bavera
- Irvine2 Vascular Laboratory and Physiology, Department of Biomedical Sciences, Chieti University, San Valentino Vascular Screening Project, Vascular Surgery, University of Milan, General Surgery, Pescara, Physiology Chieti University, Italy
- Irvine Vascular Laboratory, St Mary's Hospital and Imperial College and Vascular Unit, Ealing Hospital, London, UK
| | - M. Cacchio
- Irvine2 Vascular Laboratory and Physiology, Department of Biomedical Sciences, Chieti University, San Valentino Vascular Screening Project, Vascular Surgery, University of Milan, General Surgery, Pescara, Physiology Chieti University, Italy
- Irvine Vascular Laboratory, St Mary's Hospital and Imperial College and Vascular Unit, Ealing Hospital, London, UK
| | - M. Bucci
- Irvine2 Vascular Laboratory and Physiology, Department of Biomedical Sciences, Chieti University, San Valentino Vascular Screening Project, Vascular Surgery, University of Milan, General Surgery, Pescara, Physiology Chieti University, Italy
- Irvine Vascular Laboratory, St Mary's Hospital and Imperial College and Vascular Unit, Ealing Hospital, London, UK
| |
Collapse
|
37
|
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Ricci A, Paggiaro P. Should omalizumab be used in severe asthma/COPD overlap? J BIOL REG HOMEOS AG 2018; 32:755-761. [PMID: 30043557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
A large number of patients suffering from asthma or chronic obstructive pulmonary disease (COPD) can show overlapping features of both diseases. Several subjects affected by asthma-COPD overlap (ACO) may be at a severe stage, poorly responsive to triple therapy including inhaled corticosteroids, long-acting β2 agonists and muscarinic antagonists. This review tries to explore whether omalizumab can be used in poorly controlled severe ACO patients. According to the few studies available, omalizumab may improve asthma outcomes in ACO, although the magnitude of improvements may be lower in comparison to those obtained in subjects affected only by severe asthma. Omalizumab, by acting on IgE, might improve the eosinophilic pattern which is characteristic of the ACO asthma inflammation component. It can be hypothesized that a prevalence of Th1/Th17 airway inflammation pathways can modulate a lower response to anti-IgE while a Th2 pattern can lead to a higher effectiveness to omalizumab in ACO. High levels of IgE, FeNO and blood eosinophil count may be markers of a better response to omalizumab. In conclusion, on the basis of the few studies available, omalizumab could be effective in poorly-controlled severe ACO, although to a reduced extent in comparison to patients affected only by asthma.
Collapse
Affiliation(s)
- B Sposato
- Pneumology Department, Misericordia Hospital, Grosseto, Italy
| | - M Scalese
- Institute of Clinical Physiology, CNR, Pisa, Italy
| | - M Milanese
- Pneumology Department, S. Corona Hospital, Pietra Ligure (SV), Italy
| | - S Masieri
- Otorhinolaryngology Clinic, Policlinico Umberto I, Sapienza University, Rome, Italy
| | - C Cavaliere
- Otorhinolaryngology Clinic, Policlinico Umberto I, Sapienza University, Rome, Italy
| | - A Ricci
- Division of Pneumology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, AOU SantAndrea, Rome, Italy
| | - P Paggiaro
- Cardio Thoracic and Vascular Department, Pathophysiology Unit, University of Pisa, Italy
| |
Collapse
|
38
|
Venanzi S, Pezzolla D, Cecchini L, Pauselli M, Ricci A, Sordi A, Torquati B, Gigliotti G. Use of agricultural by-products in the development of an agro-energy chain: A case study from the Umbria region. Sci Total Environ 2018; 627:494-505. [PMID: 29426172 DOI: 10.1016/j.scitotenv.2018.01.176] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/07/2017] [Revised: 01/17/2018] [Accepted: 01/18/2018] [Indexed: 06/08/2023]
Abstract
Use of agricultural and livestock by-products for anaerobic digestion (AD), in total or partial substitution of the maize silage was evaluated from an environmental and economical point of view. The evaluation process included three methodological interdependent and consequential steps: the chemical stage at laboratory and plant level, the environmental and economic steps developing the Life Cycle Assessment and Life Cycle Costing jointly. The laboratory test showed that the two mixtures prepared with by-products, in partial (MIX A) and total (MIX B) substitution of maize silage, did not show differences in bio-methane production compared to a reference mixture with the 33% of maize silage. All mixtures tested at full-scale plant, showed the same performances, resulting in a similar energy production. Environmentally, MIX B increased greenhouse gas credits derived from the avoided production of mineral fertiliser for the energetic crops, resulting also in better economic performances. The break-even transport distances follow the positive environmental pattern result, in contrast to what was found for the break-even transport distances from the economic point of view.
Collapse
Affiliation(s)
- S Venanzi
- Department of Agricultural, Food and Environmental Sciences, University of Perugia, Borgo XX Giugno 74, 06121 Perugia, Italy
| | - D Pezzolla
- Department of Civil and Environmental Engineering, University of Perugia, Via G. Duranti 93, 06125 Perugia, Italy.
| | - L Cecchini
- Department of Agricultural, Food and Environmental Sciences, University of Perugia, Borgo XX Giugno 74, 06121 Perugia, Italy
| | - M Pauselli
- Department of Agricultural, Food and Environmental Sciences, University of Perugia, Borgo XX Giugno 74, 06121 Perugia, Italy
| | - A Ricci
- Department of Civil and Environmental Engineering, University of Perugia, Via G. Duranti 93, 06125 Perugia, Italy
| | - A Sordi
- Department of Civil and Environmental Engineering, University of Perugia, Via G. Duranti 93, 06125 Perugia, Italy
| | - B Torquati
- Department of Agricultural, Food and Environmental Sciences, University of Perugia, Borgo XX Giugno 74, 06121 Perugia, Italy
| | - G Gigliotti
- Department of Civil and Environmental Engineering, University of Perugia, Via G. Duranti 93, 06125 Perugia, Italy
| |
Collapse
|
39
|
Ricci A, Racioppi V, Iotti B, Bertero A, Reed K, Pascottini O, Vincenti L. Assessment of the temperature cut-off point by a commercial intravaginal device to predict parturition in Piedmontese beef cows. Theriogenology 2018; 113:27-33. [DOI: 10.1016/j.theriogenology.2018.02.009] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2017] [Revised: 02/06/2018] [Accepted: 02/08/2018] [Indexed: 11/29/2022]
|
40
|
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Matucci A, Vultaggio A, Ricci A, Cresti A, Santus P, Perrella A, Paggiaro PL. Factors reducing omalizumab response in severe asthma. Eur J Intern Med 2018; 52:78-85. [PMID: 29395935 DOI: 10.1016/j.ejim.2018.01.026] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/04/2017] [Revised: 01/18/2018] [Accepted: 01/23/2018] [Indexed: 12/31/2022]
Abstract
BACKGROUND Despite adding Omalizumab to conventional therapy, several severe asthmatics still show poor disease control. We investigated the factors that may affect a reduced Omalizumab response in a large population of severe asthmatics. METHODS 340 patients were retrospectively evaluated. FEV1%, FVC%, Asthma Control Test (ACT), fractional exhaled nitric oxide (FENO), possible step-downs/step-ups of concomitant therapies, exacerbations, disease control levels, ICS doses and SABA use, observed at the end of treatment, were considered as a response to Omalizumab. RESULTS Age was an independent risk factor for a reduced response concerning FEV1%, FVC%, ACT and for a lower asthma control. Obesity (vs normal weight) was a determinant condition for exacerbations (OR:3.114[1.509-6.424], p = 0.002), for a disease partial/no control (OR:2.665[1.064-6.680], p = 0.036), for excessive SABA use (OR:4.448[1.837-10.768], p = 0.002) and for an unchanged/increased level of concomitant asthma medications. Furthermore, obesity also reduced the response in FEV1 (β = -6.981,p = 0.04), FVC (β = -11.689,p = 0.014) and ACT (β = -2.585, p = 0.027) and was associated with a higher FENO level (β = 49.045,p = 0.040). Having at least one comorbidity was a risk factor for exacerbations (OR:1.383[1.128-1.697], p = 0.008) and for an ACT <20 (OR:2.410[1.071-3.690], p = 0.008). Specifically, chronic heart disease was associated with both a lower ACT and FVC% whereas gastroesophageal reflux with a partial/no asthma control. Nasal polyps were a predisposing factor leading both to exacerbations and to the use of higher inhaled corticosteroids doses. Moreover, smoking habits, pollen or dog/cat dander co-sensitizations may negatively influence Omalizumab response. CONCLUSION Age, obesity, comorbidities, smoking habits, nasal polyps, allergic poly-sensitization might reduce Omalizumab effectiveness independently to other asthma-influencing factors.
Collapse
Affiliation(s)
- B Sposato
- Pneumology Department, Misericordia Hospital, Grosseto, Italy.
| | - M Scalese
- Institute of Clinical Phisiology, CNR, Pisa, Italy
| | - M Milanese
- Pneumology Department, S.Corona Hospital, Pietra Ligure, Italy
| | - S Masieri
- Otorhinolaryngology Clinic, Policlinico Umberto I, "Sapienza" University, Roma, Italy
| | - C Cavaliere
- Otorhinolaryngology Clinic, Policlinico Umberto I, "Sapienza" University, Roma, Italy
| | - M Latorre
- Cardio Thoracic and Vascular Department, Pathophysiology Unit, University of Pisa, Italy
| | - N Scichilone
- DIMPEFINU, Unit of Pneumology and Medicine, University of Palermo, Italy
| | - A Matucci
- Immunoallergology Unit, Department of Medicine and Geriatric, AOU Careggi, Florence, Italy
| | - A Vultaggio
- Immunoallergology Unit, Department of Medicine and Geriatric, AOU Careggi, Florence, Italy
| | - A Ricci
- Division of Pneumology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, AOU Sant'Andrea, Rome, Italy
| | - A Cresti
- Cardiology Department, Misericordia Hospital, Grosseto, Italy
| | - P Santus
- Department of Biomedical And Clinical Sciences (DIBIC), University of Milan, Respiratory Unit, "Luigi Sacco" University Hospital; ASST Fatebenefratelli-Sacco, Milan, Italy
| | - A Perrella
- Pneumology Department, Misericordia Hospital, Grosseto, Italy
| | - P L Paggiaro
- Cardio Thoracic and Vascular Department, Pathophysiology Unit, University of Pisa, Italy
| |
Collapse
|
41
|
Clerici CA, Quarello P, Bergadano A, Veneroni L, Bertolotti M, Guadagna P, Ricci A, Galdi A, Fagioli F, Ferrari A. Proper use of social media by health operators in the pediatric oncohematological setting: Consensus statement from the Italian Pediatric Hematology and Oncology Association (AIEOP). Pediatr Blood Cancer 2018; 65:e26958. [PMID: 29316150 DOI: 10.1002/pbc.26958] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/07/2017] [Revised: 12/05/2017] [Accepted: 12/12/2017] [Indexed: 11/07/2022]
Abstract
Social media are powerful means of communication that can also have an important role in the healthcare sector. They are sometimes seen with diffidence in the healthcare setting, partly because they risk blurring professional boundaries. This issue is particularly relevant to relations between caregivers and adolescent patients. The Italian Pediatric Hematology and Oncology Association created a multidisciplinary working group to develop some shared recommendations on this issue. After reviewing the literature, the working group prepared a consensus statement in an effort to suggest an analytical approach rather than restrictive rules.
Collapse
Affiliation(s)
- Carlo Alfredo Clerici
- Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.,Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
| | - Paola Quarello
- Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Turin, Italy
| | - Anna Bergadano
- Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Turin, Italy
| | - Laura Veneroni
- Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
| | - Marina Bertolotti
- Psycho-Oncology Service, Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Turin, Italy
| | - Paola Guadagna
- Pediatric Hemato-Oncology Unit, Arnas Civico, ASLTI Liberi di crescere Onlus, Palermo, Italy
| | - Angelo Ricci
- Federazione Italiana Associazioni Genitori Oncoematologia Pediatrica (FIAGOP), Modena, Italy
| | | | - Franca Fagioli
- Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Turin, Italy
| | - Andrea Ferrari
- Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
| |
Collapse
|
42
|
Antonini L, Garzoli S, Ricci A, Troiani A, Salvitti C, Giacomello P, Ragno R, Patsilinakos A, Di Rienzo B, Pepi F. Ab-initio and experimental study of pentose sugar dehydration mechanism in the gas phase. Carbohydr Res 2018; 458-459:19-28. [PMID: 29428483 DOI: 10.1016/j.carres.2018.01.007] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2017] [Revised: 01/26/2018] [Accepted: 01/29/2018] [Indexed: 11/26/2022]
|
43
|
Poola I, Yue Q, Gillespie J, Shaaban A, Rao J, Sullivan P, Aguilar-Jakthong J, Sauter E, Ricci A. Abstract P4-09-05: Withdrawn. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p4-09-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was withdrawn by the authors.
Collapse
Affiliation(s)
- I Poola
- Silbiotech, Inc, Gaithersburg, MD; Leeds Hospital and University of Birmingham, Leeds, United Kingdom; UCLA School of Medicine, Los Angeles, CA; Hartford Hospital and University of Connecticut School of Medicine, Hartford, CT
| | - Q Yue
- Silbiotech, Inc, Gaithersburg, MD; Leeds Hospital and University of Birmingham, Leeds, United Kingdom; UCLA School of Medicine, Los Angeles, CA; Hartford Hospital and University of Connecticut School of Medicine, Hartford, CT
| | - J Gillespie
- Silbiotech, Inc, Gaithersburg, MD; Leeds Hospital and University of Birmingham, Leeds, United Kingdom; UCLA School of Medicine, Los Angeles, CA; Hartford Hospital and University of Connecticut School of Medicine, Hartford, CT
| | - A Shaaban
- Silbiotech, Inc, Gaithersburg, MD; Leeds Hospital and University of Birmingham, Leeds, United Kingdom; UCLA School of Medicine, Los Angeles, CA; Hartford Hospital and University of Connecticut School of Medicine, Hartford, CT
| | - J Rao
- Silbiotech, Inc, Gaithersburg, MD; Leeds Hospital and University of Birmingham, Leeds, United Kingdom; UCLA School of Medicine, Los Angeles, CA; Hartford Hospital and University of Connecticut School of Medicine, Hartford, CT
| | - P Sullivan
- Silbiotech, Inc, Gaithersburg, MD; Leeds Hospital and University of Birmingham, Leeds, United Kingdom; UCLA School of Medicine, Los Angeles, CA; Hartford Hospital and University of Connecticut School of Medicine, Hartford, CT
| | - J Aguilar-Jakthong
- Silbiotech, Inc, Gaithersburg, MD; Leeds Hospital and University of Birmingham, Leeds, United Kingdom; UCLA School of Medicine, Los Angeles, CA; Hartford Hospital and University of Connecticut School of Medicine, Hartford, CT
| | - E Sauter
- Silbiotech, Inc, Gaithersburg, MD; Leeds Hospital and University of Birmingham, Leeds, United Kingdom; UCLA School of Medicine, Los Angeles, CA; Hartford Hospital and University of Connecticut School of Medicine, Hartford, CT
| | - A Ricci
- Silbiotech, Inc, Gaithersburg, MD; Leeds Hospital and University of Birmingham, Leeds, United Kingdom; UCLA School of Medicine, Los Angeles, CA; Hartford Hospital and University of Connecticut School of Medicine, Hartford, CT
| |
Collapse
|
44
|
Trapani S, Rizzato L, Masiero L, Ricci A, Morabito V, Peritore D, Fiaschetti P, Del Sordo E, Cacciotti AR, Montemurro A, Nanni Costa A. Hepatitis C Virus Positive Patients on the Waiting List for Liver Transplantation: Turnover and Characteristics of the Population on the Eve of the Therapeutic Revolution With Direct-Acting Antivirals. Transplant Proc 2017; 49:658-666. [PMID: 28457366 DOI: 10.1016/j.transproceed.2017.02.039] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
INTRODUCTION Antivirals direct acting (DAA) for hepatitis C virus (HCV) have brought a revolution in the field of transplantation. It is likely to think that in the future patients on the waiting list for liver transplantation (LT) will no longer be registered for HCV-related cirrhosis but for liver disease from other causes. On the eve of this change, we show a snapshot of the Italian waiting list for LT. METHODS From October 1, 2012 to September 30, 2013, we estimated the total number of patients on the liver waiting list as intention to treat (ITT), the number of incident cases, and the delistings, particularly in the HCV positive (HCV+) population. Gender, median age, etiology and prognosis of liver disease, presence of hepatocellular carcinoma (HCC), reason for delisting, mean waiting time for LT, and rate of death on waiting list were evaluated. RESULTS In the time period, there were 517 new patients who were HCV+ (median age, 53 years): 255 (49.3%) mono-infected with HCV, 236 (45.7%) co-infected with HCV and hepatitis B virus (HBV), 11 (2.1%) co-infected with HCV and human immunodeficiency virus (HIV), and 15 (2.9%) co-infected with HCV, HBV, and HIV. The median model for end-stage liver disease (MELD) score at listing was 17 and HCC was present in 206 (39.8%) cases. HCV+ patients delisted were 442 (61.9%), 355 (80.3%) for LT. The mean waiting time to transplantation was 1.9 months; the percentage of death was 7.6%. CONCLUSIONS This snapshot of the waiting list for LT in the year before the advent of DAA drugs will allow us to assess whether and how they will change the waiting list for LT when we start to look at the impact of new therapies on the waiting list.
Collapse
Affiliation(s)
- S Trapani
- Italian National Transplant Center, Rome, Italy.
| | - L Rizzato
- Italian National Transplant Center, Rome, Italy
| | - L Masiero
- Italian National Transplant Center, Rome, Italy
| | - A Ricci
- Italian National Transplant Center, Rome, Italy
| | - V Morabito
- Italian National Transplant Center, Rome, Italy
| | - D Peritore
- Italian National Transplant Center, Rome, Italy
| | | | - E Del Sordo
- Italian National Transplant Center, Rome, Italy
| | | | | | | |
Collapse
|
45
|
Ricci A, Carvalho P, Amundson M, Fricke P. Characterization of luteal dynamics in lactating Holstein cows for 32 days after synchronization of ovulation and timed artificial insemination. J Dairy Sci 2017; 100:9851-9860. [DOI: 10.3168/jds.2017-13293] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2017] [Accepted: 08/21/2017] [Indexed: 01/03/2023]
|
46
|
|
47
|
Ricci A, Bonizzi G, Sarasso G, Gallo S, Dondo A, Zoppi S, Vincenti L. Subclinical endometritis in beef cattle in early and late postpartum: Cytology, bacteriology, haptoglobin and test strip efficiency to evaluate the evolution of the disease. Theriogenology 2017; 94:86-93. [DOI: 10.1016/j.theriogenology.2017.02.006] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2016] [Revised: 02/08/2017] [Accepted: 02/09/2017] [Indexed: 10/20/2022]
|
48
|
Bertero A, Ritrovato F, Evangelista F, Stabile V, Fortina R, Ricci A, Revelli A, Vincenti L, Nervo T. Evaluation of equine oocyte developmental competence using polarized light microscopy. Reproduction 2017; 153:775-784. [PMID: 28283673 DOI: 10.1530/rep-17-0125] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2017] [Revised: 03/03/2017] [Accepted: 03/09/2017] [Indexed: 12/28/2022]
Abstract
The purpose of this study was to observe in vitro-matured equine oocytes with an objective computerized technique that involves the use of a polarized light microscope (PLM) in addition to the subjective morphological evaluation obtained using a classic light microscope (LM). Equine cumulus-oocyte complexes (COCs, n = 922) were subjected to different in vitro maturation times (24, 36 or 45 h), however, only 36-h matured oocytes were analyzed using CLM. The 36-h matured oocytes that reached maturity were parthenogenetically activated to evaluate the quality and meiotic competence. Average maturation percentages per session in groups 1, 2 and 3 (24-, 36- and 45-h matured oocytes respectively) were 29.31 ± 13.85, 47.01 ± 9.90 and 36.62 ± 5.28%, whereas the average percentages of immature oocytes per session were 28.78 ± 20.17, 7.83 ± 5.51 and 22.36 ± 8.39% respectively. The zona pellucida (ZP) birefringent properties were estimated and correlated with activation outcome. ZP thickness and retardance of the inner layer of the zona pellucida (IL-ZP) were significantly increased in immature oocytes compared with mature oocytes (P < 0.001 and P < 0.01 respectively). The comparison between parthenogenetically activated and non-activated oocytes showed a significant increase in the area and thickness of the IL-ZP in parthenogenetically activated oocytes (P < 0.01). These results show that the 36-h in vitro maturation (IVM) protocol allowed equine oocytes to reach maturity, and PLM observation of ZP can be used to distinguish mature and immature oocytes as well as activated and non-activated oocytes.
Collapse
Affiliation(s)
- A Bertero
- Department of Veterinary ScienceUniversity of Torino, Grugliasco, Italy
| | - F Ritrovato
- Department of Surgical SciencesUniversity of Torino, S. Anna Hospital, Torino, Italy
| | - F Evangelista
- Department of Surgical SciencesUniversity of Torino, S. Anna Hospital, Torino, Italy
| | - V Stabile
- Department of Surgical SciencesUniversity of Torino, S. Anna Hospital, Torino, Italy
| | - R Fortina
- Department of AgriculturalForestry and Food Sciences, University of Torino, Grugliasco, Italy
| | - A Ricci
- Department of Veterinary ScienceUniversity of Torino, Grugliasco, Italy
| | - A Revelli
- Department of Surgical SciencesUniversity of Torino, S. Anna Hospital, Torino, Italy
| | - L Vincenti
- Department of Veterinary ScienceUniversity of Torino, Grugliasco, Italy
| | - T Nervo
- Department of Veterinary ScienceUniversity of Torino, Grugliasco, Italy
| |
Collapse
|
49
|
Ricci A, Bonini S, Continanza M, Turano MT, Puliti EM, Finocchietti A, Bertolucci D. Worry and anger rumination in fibromyalgia syndrome. Reumatismo 2016; 68:195-198. [PMID: 28299918 DOI: 10.4081/reumatismo.2016.896] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2016] [Revised: 11/10/2016] [Accepted: 12/22/2016] [Indexed: 11/23/2022] Open
Abstract
The aim of the present study was twofold: 1) to investigate the psychological profile of patients with fibromyalgia syndrome (FS) as compared to patients with other chronic pain syndromes (CP) and healthy subjects (HS); 2) to examine the associations between anxiety, depression, worry and angry rumination in FS patients. FS patients (N=30), CP patients (N=30) and HS (N=30) completed measurements of anxiety, depression, worry and angry rumination. FS patients showed higher levels of state and trait anxiety, worry and angry rumination than CP patients and HS, and higher levels of depression than HS. Worry and angry rumination were strongly associated in the FS group. FS patients may use worry and rumination as coping strategies to deal with their negative emotional experience, which might impair their emotional wellbeing. Findings from the present study add to our understanding of the psychological profile of FS patients, and have important implications for developing a tailored CBT protocol for pain management in FS patients.
Collapse
|
50
|
Belcaro G, Dugall M, Luzzi R, Corsi M, Ledda A, Ricci A, Pellegrini L, Cesarone MR, Hosoi M, Errichi BM, Cornelli U, Cotellese R, Agus G, Feragalli B. Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings. Int J Angiol 2016; 26:170-178. [PMID: 28804235 DOI: 10.1055/s-0036-1597756] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
Abstract
The aim of this registry study was to compare products used to control symptoms of CVI. Endpoints of the study were microcirculation, effects on volume changes, and symptoms (analogue scale). Pycnogenol, venoruton, troxerutin, the complex diosmin-hesperidin, Antistax, Mirtoselect (bilberry), escin, and the combination Venoruton-Pycnogenol (VE-PY) were compared with compressions. No safety or tolerability problems were observed. At inclusion, measurements in the groups were comparable: 1,051 patients completed the registry. Best performers : Venoruton, Pycnogenol, and the combination VE-PY produced the best effects on skin flux. These products and the combination VE-PY better improved PO 2 and PCO 2 . The edema score was decreased more effectively with the combination and with Pycnogenol. Venoruton; Antistax also had good results. Considering volumetry, the best performers were the combination PY-VE and the two single products Venoruton and Pycnogenol. Antistax results for edema were also good. The best improvement in symptoms score were obtained with Pycnogenol and compression. A larger decrease in oxidative stress was observed with Pycnogenol, Venoruton, and with the VE-PY combination. Good effects of Antistax were also observed. Parestesias were lower with Pycnogenol and with Antistax. Considering the need for interventions, the best performers were Pycnogenol, VE-PY, and compression. The efficacy of Pycnogenol and the combination are competitive with stockings that do not have the same tolerability in warmer climates. A larger and more prolonged evaluation is suggested to evaluate cost-efficacy (and non-interference with drugs) of these products in the management of CVI. The registry is in progress; other products are in evaluation.
Collapse
Affiliation(s)
- G Belcaro
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - M Dugall
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - R Luzzi
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - M Corsi
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - A Ledda
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - A Ricci
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - L Pellegrini
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - M R Cesarone
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - M Hosoi
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - B M Errichi
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - U Cornelli
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - R Cotellese
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - G Agus
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| | - B Feragalli
- Irvine 3 Labs, Circulation Sciences, CH-PE University, Italy
| |
Collapse
|